Strengthen network information management, build a solid enterprise security line of defense
Release time:
2021-09-22
News from our newspaper 9# February 17 , the group company held a network information security meeting to comprehensively evaluate the network information security management and protection level of each unit and deploy the improvement of network information security management in view of the recent hacker attacks and blackmail incidents and handling results of subordinate enterprises.
9# July15 The group's subordinate enterprises in Jin suffered a blackmail virus attack, which seriously affected its production and operation. The police reported that it was a new type of virus, and many Chinese companies were also attacked by similar types. It has the characteristics of strong concealment, long incubation period, high destructive power, and high difficulty in tracking.
It is understood that the2020 neo-coronary pneumonia epidemic has accelerated the global digital transformation process while also catalyzing an outbreak of global cyber threats. According to Tencent's "Report on Extortion Virus Trend in the First Half of 2021 and Recommendations on Protection Schemes" released by Tencent Security, in the first quarter of 2021 alone, there were many cases of internationally renowned enterprises being extorted, and ransom payments continued to set new records. With the continuous improvement of informatization, automation and intelligence in the production and operation of enterprises, the importance of network information security is becoming more and more obvious, and the threat of information security is also increasing day by day.
After the meeting notified the blackmail virus incident, the person in charge of network information of each unit introduced their own network security situation and existing problems, and provided many constructive suggestions on how to strengthen network security protection. opinion. Xiang Chongping, deputy general manager ofgroup company, pointed out in his concluding speech that with the further promotion of digitalization, intelligence and informatization of enterprises, the production, operation and daily operation of enterprises increasingly rely on networks and software, and computer network systems affect the whole body. Group companies should attach great importance to network information security, Managers at all levels should fully realize the importance of strengthening network security. Secondly, build a network security system from the system, starting from the group, formulate and improve the network information management system from top to bottom, including software system management, hardware equipment management, computer room management, storage equipment management, etc. Thirdly, it is necessary to improve the professional level of the technical personnel of each unit, improve the emergency handling ability, and do a good job in the professional skills training and information exchange of technical personnel to deal with the possible network security crisis. In view of the old equipment of many units, Xiang Chongping asked all units to increase investment in network facilities and equipment, improve the stability and anti-interference ability of software and hardware, constantly improve the information construction, build a solid defense line of enterprise network security, and put an end to the occurrence of network security accidents. (Chi Lifan
Chen Shengmu)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page